Login / Signup

Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurology.

Gregory A JichaErin L AbnerElif P CoskunMark J HuffmyerThomas C TuckerPeter T Nelson
Published in: Alzheimer's & dementia (New York, N. Y.) (2024)
Anti-amyloid therapy costs are comparable to other commonly used biologics.Anti-amyloid therapy efficacy is comparable to other commonly used biologics.Anti-amyloid therapy safety is compatible with other commonly used biologics.
Keyphrases
  • squamous cell carcinoma
  • stem cells
  • papillary thyroid
  • cognitive decline
  • combination therapy
  • replacement therapy
  • mild cognitive impairment